New England Journal of Medicine, Volume 390, Issue 11, Page 973-983, March 2024.
Risultati per: Nuovo test per distinguere tra infezioni virali e batteriche
Questo è quello che abbiamo trovato per te
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening
New England Journal of Medicine, Volume 390, Issue 11, Page 984-993, March 2024.
Studies to Test How Well PREVENT Predicts Heart Disease in Diverse Groups
Researchers have begun studying how accurately a new tool, known as the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator, estimates risk in people from different racial and ethnic backgrounds as well as from a range of ages, the American Heart Association announced. Three research teams will evaluate the new scores using larger databases and will assess PREVENT’s fairness and cost-effectiveness compared with the Pooled Cohort Equations (PCEs).
Sale l’allerta Dengue negli aeroporti: test ai passeggeri in arrivo dai Paesi a rischio
Una nuova circolare a quasi un mese dalla prima diffusa dalla direzione della Prevenzione del ministero della Salute
Using reference equations to standardise incremental shuttle walk test performance in children and young people with chronic conditions and facilitate the evaluation of exercise capacity and disease severity
Aims
The aim was to evaluate whether standardised exercise performance during the incremental shuttle walk test (ISWT) can be used to assess disease severity in children and young people (CYP) with chronic conditions, through (1) identifying the most appropriate paediatric normative reference equation for the ISWT, (2) assessing how well CYP with haemophilia and cystic fibrosis (CF) perform against the values predicted by the best fit reference equation and (3) evaluating the association between standardised ISWT performance and disease severity.
Methods
A cross-sectional analysis was carried out using existing data from two independent studies (2018–2019) at paediatric hospitals in London,UK. CYP with haemophilia (n=35) and CF (n=134) aged 5–18 years were included. Published reference equations for standardising ISWT were evaluated through a comparison of populations, and Bland-Altman analysis was used to assess the level of agreement between distances predicted by each equation. Associations between ISWT and disease severity were assessed with linear regression.
Results
Three relevant reference equations were identified for the ISWT that standardised performance based on age, sex and body mass index (Vardhan, Lanza, Pinho). A systematic proportional bias of standardised ISWT was observed in all equations, most pronounced with Vardhan and Lanza; the male Pinho equation was identified as most appropriate. On average, CYP with CF and haemophilia performed worse than predicted by the Pihno equation, although the range was wide. Standardised ISWT, and not ISWT distance alone, was significantly associated with forced expiratory volume in 1 s in CYP with CF. Standardised ISWT in CYP with haemophilia was slightly associated with haemophilia joint health score, but this was not significant.
Conclusions
ISWT performance may be useful in a clinic to identify those with worsening disease, but only when performance is standardised against a healthy reference population. The development of validated global reference equations is necessary for more robust assessment.
Arriva un test rapido per la diagnosi del diabete e pre-diabete
Sesti (Simi), ‘intercetta precocemente i soggetti a rischio. Cure più tempestive’
'Family-based strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat strategy
We read with utmost interest the study by Zhou et al,1 which was the first family-based investigation of Helicobacter pylori (Hp) infection in China. The authors provided valuable insights into the occurrence of familial cluster effect on Hp infection and the superiority of the ‘family-based strategy’. However, their work failed to compare the screening efficiency of various established Hp management methods, leaving us curious about whether the ‘family-based strategy’ could identify more Hp-infected participants with equal number of tests conducted as compared with the widely used ‘test and treat strategy’.2 Fortunately, the family-unit data in Zhou’s study offers the possibility for such exploration. To address this gap, we built a database consisting of over one million households, based on the infection status of households and individuals from 29 provinces reported by Zhou, in order to simulate real-world scenarios. The screening protocols were simulated in national…
Attività motoria dalla scuola d'infanzia, test in Emilia-Romagna
Iniziativa apripista, saranno coinvolti 2.500 bimbi di 4-5 anni
Celiac disease-related conditions: Who to test?
Celiac disease (CeD) is a chronic immune-mediated condition triggered by gluten consumption in genetically predisposed individuals. Approximately 1% of the general population is affected by the disorder. Disease presentation is heterogeneous, and despite growing awareness among physicians and the public, it continues to be underestimated. The most effective strategy for identifying undiagnosed CeD is proactive case-finding through serologic testing in high-risk groups. We reviewed the most recent evidence on the association between CeD and over 20 conditions.
Prevalence of Sessile Serrated Lesions in Individuals with Positive Fecal Immunochemical Test Undergoing Colonoscopy: Results from a Large Nationwide Veterans Affairs Database
Ogni anno 12.000 decessi per infezioni resistenti a antibiotici
A Torino primo evento della campagna Diagnostica e prevenzione
Commercial Blood Test May Identify Alzheimer Disease Brain Pathology
A commercially available blood test that measures levels of a tau protein known as phosphorylated tau 217, or p-tau217, was able to identify people whose brains showed signs of Alzheimer disease pathology, according to data from an observational study. The research involved about 800 participants with and without cognitive impairment.
Diagnostic performance evaluation of urine HIV-1 antibody rapid test kits in a real-life routine care setting in China
Objectives
To evaluate the diagnostic performance of urine HIV antibody rapid test kits in screening diverse populations and to analyse subjects’ willingness regarding reagent types, purchase channels, acceptable prices, and self-testing.
Designs
Diagnostic accuracy studies
Participants
A total of 2606 valid and eligible samples were collected in the study, including 202 samples from female sex workers (FSWs), 304 persons with injection drug use (IDU), 1000 pregnant women (PW), 100 subjects undergoing voluntary HIV counselling and testing (VCT) and 1000 students in higher education schools or colleges (STUs). Subjects should simultaneously meet the following inclusion criteria: (1) being at least 18 years old and in full civil capacity, (2) signing an informed consent form and (3) providing truthful identifying information to ensure that the subjects and their samples are unique.
Results
The sensitivity, specificity and area under the curve (AUC) of the urine HIV-1 antibody rapid test kits were 92.16%, 99.92% and 0.960 (95% CI: 0.952 to 0.968, p
Morbillo, nell'area di Milano nuova variante che può sfuggire a test
Studio, individuati 5 casi, analogie con contagi in Svizzera
Dalle infezioni resistenti costi per un miliardo l'anno
Cittadinanzattiva lancia una Roadmap con 10 priorità
Verso un test delle urine per la diagnosi precoce del cancro alle ovaie
Miglioramento della sopravvivenza a 5 anni se il tumore è in fase precoce